Onset Time of Thiopental Versus Propofol in the Elderly
This study has been completed.
Sponsor:
Rigshospitalet, Denmark
Collaborator:
TrygFonden, Denmark
Information provided by:
Rigshospitalet, Denmark
ClinicalTrials.gov Identifier:
NCT00965107
First received: August 24, 2009
Last updated: March 8, 2010
Last verified: February 2010
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
This study is aimed at increasing the safety of the use of anaesthesia in an elderly population (> 60 years). Patients with decreased physiological reserve, including all elderly patients, have an increased risk of getting an erroneous induction bolus. This project will investigate how fast elderly patients (> 60 years) fall asleep during bolus induction of anaesthesia with two of the most used hypnotics, thiopental and propofol, evaluated with BIS-monitoring and clinical signs of anaesthetic depth. The hemodynamic response will also be evaluated.
| Condition | Intervention | Phase |
|---|---|---|
|
Induction of Anaesthesia Age |
Drug: Thiopental Drug: Propofol |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Double Blind (Subject, Investigator, Outcomes Assessor) Primary Purpose: Treatment |
| Official Title: | Onset Time of Thiopental Versus Propofol in the Elderly |
Resource links provided by NLM:
Further study details as provided by Rigshospitalet, Denmark:
Primary Outcome Measures:
- "Onset-time" defined as the time from started induction bolus to: - Time to BIS-value <50. [ Time Frame: 120 seconds ] [ Designated as safety issue: Yes ]
Secondary Outcome Measures:
- Hemodynamical effect (bloodpressure/pulse) every 60 seconds. [ Time Frame: 120 seconds ] [ Designated as safety issue: Yes ]
- "Onset-time" defined as the time from started induction bolus to: - Time to loss of grip. [ Time Frame: 120 seconds ] [ Designated as safety issue: Yes ]
- "Onset-time" defined as the time from started induction bolus to: - Time to eye closure. [ Time Frame: 120 seconds ] [ Designated as safety issue: Yes ]
- "Onset-time" defined as the time from started induction bolus to: - Time to ciliary reflex cessation. [ Time Frame: 120 seconds ] [ Designated as safety issue: Yes ]
| Estimated Enrollment: | 78 |
| Study Start Date: | September 2009 |
| Study Completion Date: | March 2010 |
| Primary Completion Date: | March 2010 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: Thiopental
Thiopental for induction of anaesthesia.
|
Drug: Thiopental
Thiopental given as a bolus dose of 2,5 mg/kg.
Other Name: Thiomebumalnatrium, thiomebumal
|
|
Active Comparator: Propofol
Propofol for induction of anaesthesia.
|
Drug: Propofol
Propofol given as a bolus dose of 1 mg/kg.
|
Eligibility| Ages Eligible for Study: | 60 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Criteria
Inclusion Criteria:
- Elective surgical patients above 60 years of age, with an indication of general anaesthesia during surgery.
- Informed consent.
- The patient must be legally competent.
- The patient must be able to read and understand Danish.
Exclusion Criteria:
- Known allergic reactions to thiopental, propofol, lidocaine or alfentanil
- "Body Mass Index" (BMI) <18 and > 35.
- NYHA-class > 2.
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00965107
Locations
| Denmark | |
| Department of Anesthesia, Center of Head and Orthopedics, Copenhagen University Hospital Rigshospitalet | |
| Copenhagen, Denmark, 2100 | |
| Department of Anesthesia, Juliane Marie Center, Copenhagen University Hospital Rigshospitalet | |
| Copenhagen, Denmark, 2100 | |
Sponsors and Collaborators
Rigshospitalet, Denmark
TrygFonden, Denmark
Investigators
| Principal Investigator: | Lars Rasmussen, MD, PHD | Rigshospitalet, Denmark |
| Principal Investigator: | Martin K Soerensen, MD | Rigshospitalet, Denmark |
More Information
No publications provided
| Responsible Party: | Lars Rasmussen, Department of Anesthesia, Center of Head and Orthopedics, Copenhagen University Hospital Rigshospitalet |
| ClinicalTrials.gov Identifier: | NCT00965107 History of Changes |
| Other Study ID Numbers: | 1A-AGE/ONSET |
| Study First Received: | August 24, 2009 |
| Last Updated: | March 8, 2010 |
| Health Authority: | Denmark: Danish Dataprotection Agency Denmark: The Danish National Committee on Biomedical Research Ethics Denmark: The Danish Medicines Agency |
Additional relevant MeSH terms:
|
Propofol Thiopental Anesthetics, Intravenous Anesthetics, General Anesthetics Central Nervous System Depressants Physiological Effects of Drugs Pharmacologic Actions |
Central Nervous System Agents Therapeutic Uses Hypnotics and Sedatives GABA Modulators GABA Agents Neurotransmitter Agents Molecular Mechanisms of Pharmacological Action Anticonvulsants |
ClinicalTrials.gov processed this record on May 23, 2013